Oncternal Therapeutics, Inc. (ONCT) Q1 2021 Earnings Call Transcript

Oncternal Therapeutics, Inc. (ONCT) Q1 2021 Earnings Call Transcript

Joining me on the call this afternoon are our president and CEO, Dr. James Breitmeyer; and our acting CMO, Dr. Today's call includes a business update and discussion of our 2021 first-quarter financial results which will be followed by Q&A. Today's press release and replay of today's earnings call will be available on the Investor Relations section of Oncternal's website for at least the next 30 days.